O'Keefe Stevens Advisory’s Calumet Specialty Products CLMT Stock Holding History

O'Keefe Stevens Advisory’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.59M	Buy	30,435 +1,460	+5%	+$69.1K	0.33%	36
2026 Q2	$1.04M	Buy	28,975 +540	+2%	+$18.2K	0.21%	44
2026 Q1	$1.02M	Buy	28,435 +1,055	+4%	+$27.3K	0.25%	45
2025 Q4	$544K	Sell	27,380 -36	-0.1%	-$693	0.14%	49
2025 Q3	$500K	Buy	27,416 +599	+2%	+$9.9K	0.14%	49
2025 Q2	$423K	Buy	26,817 +2,903	+12%	+$36.9K	0.12%	53
2025 Q1	$303K	Buy	23,914 +4,495	+23%	+$70.6K	0.1%	54
2024 Q4	$428K	Buy	+19,419	New	+$408K	0.13%	52

Other funds holding CLMT

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Hennessy Advisors Inc Novato, California $2.66B AUM 26.6% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

O'Keefe Stevens Advisory's CLMT Position: Q3 2026 in Review

O'Keefe Stevens Advisory increased its Calumet Specialty Products (CLMT) stake by 5% in Q3 2026, buying an estimated $69.1K and bringing the position to 30,435 shares worth $1.59M. The position accounts for 0.33% of the portfolio, ranked #36.

O'Keefe Stevens Advisory first reported a position in CLMT in Q4 2024 and has held it in 8 quarters since. 81 funds tracked by Wall St. Rank hold CLMT as of Q3 2026.

O'Keefe Stevens Advisory held 30,435 shares of Calumet Specialty Products worth $1.59M as of Q3 2026.
O'Keefe Stevens Advisory bought 1,460 Calumet Specialty Products shares in Q3 2026, an estimated $69.1K.
Calumet Specialty Products made up 0.33% of O'Keefe Stevens Advisory's portfolio in Q3 2026, its #36 holding.
O'Keefe Stevens Advisory first reported a position in Calumet Specialty Products in Q4 2024 and has held it in 8 quarters since.
81 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2026.

Based on O'Keefe Stevens Advisory's 13F filing for Q3 2026, filed 9 Oct 2026.